Bank of Montreal’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$338M Sell
961,165
-122,655
-11% -$43.7M 0.13% 143
2025
Q4
$355M Buy
1,083,820
+20,741
+2% +$6.58M 0.12% 130
2025
Q3
$300M Buy
1,063,079
+53,566
+5% +$15.5M 0.12% 141
2025
Q2
$282M Sell
1,009,513
-118,300
-10% -$33.5M 0.13% 127
2025
Q1
$351M Sell
1,127,813
-216,606
-16% -$64M 0.17% 111
2024
Q4
$350M Buy
1,344,419
+46,030
+4% +$13.7M 0.16% 114
2024
Q3
$419M Buy
1,298,389
+2,787
+0.2% +$912K 0.18% 99
2024
Q2
$415M Buy
1,295,602
+73,041
+6% +$21.5M 0.12% 102
2024
Q1
$350M Sell
1,222,561
-579,702
-32% -$170M 0.11% 120
2023
Q4
$520M Buy
1,802,263
+549,111
+44% +$150M 0.16% 85
2023
Q3
$328M Buy
1,253,152
+186,365
+17% +$46.5M 0.11% 112
2023
Q2
$272M Buy
1,066,787
+116,076
+12% +$26.9M 0.09% 120
2023
Q1
$243M Sell
950,711
-58,222
-6% -$14.3M 0.1% 124
2022
Q4
$265M Buy
1,008,933
+164,165
+19% +$44M 0.12% 114
2022
Q3
$216K Sell
844,768
-263,571
-24% -$63.9M 0.09% 132
2022
Q2
$283K Sell
1,108,339
-293,861
-21% -$72M 0.13% 114
2022
Q1
$358M Sell
1,402,200
-75,085
-5% -$17.3M 0.17% 106
2021
Q4
$377M Sell
1,477,285
-212,178
-13% -$44.8M 0.2% 100
2021
Q3
$431M Sell
1,689,463
-669,299
-28% -$154M 0.2% 94
2021
Q2
$602M Buy
2,358,762
+1,094,366
+87% +$269M 0.3% 66
2021
Q1
$312M Sell
1,264,396
-296,490
-19% -$70.7M 0.2% 101
2020
Q4
$371M Buy
1,560,886
+254,085
+19% +$58.6M 0.25% 89
2020
Q3
$330M Sell
1,306,801
-22,979
-2% -$5.69M 0.28% 82
2020
Q2
$335M Buy
1,329,780
+36,999
+3% +$8.44M 0.3% 72
2020
Q1
$270M Sell
1,292,781
-217,888
-14% -$47.6M 0.31% 70
2019
Q4
$364M Buy
1,510,669
+209,407
+16% +$46.2M 0.27% 70
2019
Q3
$252M Sell
1,301,262
-419,932
-24% -$80.6M 0.22% 87
2019
Q2
$317M Sell
1,721,194
-291,695
-14% -$52.2M 0.27% 80
2019
Q1
$382M Sell
2,012,889
-575,048
-22% -$110M 0.33% 64
2018
Q4
$504M Buy
2,587,937
+259,080
+11% +$50.5M 0.48% 43
2018
Q3
$483M Buy
2,328,857
+275,469
+13% +$54.3M 0.38% 54
2018
Q2
$379M Sell
2,053,388
-132,005
-6% -$23.3M 0.31% 60
2018
Q1
$373M Sell
2,185,393
-426,957
-16% -$78.4M 0.33% 55
2017
Q4
$454M Sell
2,612,350
-62,890
-2% -$11.1M 0.39% 49
2017
Q3
$499M Sell
2,675,240
-70,389
-3% -$12.5M 0.46% 42
2017
Q2
$473M Sell
2,745,629
-91,827
-3% -$14.9M 0.45% 39
2017
Q1
$466M Buy
2,837,456
+269,586
+10% +$44.8M 0.44% 39
2016
Q4
$370M Buy
2,567,870
+86,313
+3% +$13M 0.39% 45
2016
Q3
$414M Sell
2,481,557
-35,937
-1% -$6.08M 0.45% 41
2016
Q2
$383M Buy
2,517,494
+116,663
+5% +$18.1M 0.44% 41
2016
Q1
$360M Sell
2,400,831
-247,551
-9% -$36.8M 0.38% 46
2015
Q4
$430M Buy
2,648,382
+332,329
+14% +$52.2M 0.51% 34
2015
Q3
$320M Buy
2,316,053
+198,113
+9% +$31.2M 0.44% 40
2015
Q2
$325M Buy
2,117,940
+255,245
+14% +$40.9M 0.38% 46
2015
Q1
$298M Buy
1,862,695
+328,433
+21% +$51.7M 0.34% 58
2014
Q4
$244M Sell
1,534,262
-665,680
-30% -$104M 0.28% 70
2014
Q3
$309M Buy
2,199,942
+398,972
+22% +$52.1M 0.35% 58
2014
Q2
$0 Buy
1,800,970
+97,797
+6% +$11.3M ﹤0.01% 4658
2014
Q1
$210M Sell
1,703,173
-645,042
-27% -$78.2M 0.27% 80
2013
Q4
$268M Sell
2,348,215
-230,341
-9% -$26.2M 0.37% 53
2013
Q3
$289M Sell
2,578,556
-270,569
-9% -$29.3M 0.45% 39
2013
Q2
$281M Buy
+2,849,125
New +$296M 0.5% 36

Other funds holding AMGN

Bank of Montreal's AMGN Position: Q1 2026 in Review

Bank of Montreal reduced its Amgen (AMGN) stake by 11% in Q1 2026, selling an estimated $43.7M and leaving 961,165 shares worth $338M. The position accounts for 0.13% of the portfolio, ranked #143.

Bank of Montreal first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $602M in Q2 2021. 3,132 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bank of Montreal held 961,165 shares of Amgen worth $338M as of Q1 2026.
  • Bank of Montreal sold 122,655 Amgen shares in Q1 2026, an estimated $43.7M.
  • Amgen made up 0.13% of Bank of Montreal's portfolio in Q1 2026, its #143 holding.
  • Bank of Montreal first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's Amgen position peaked at $602M in Q2 2021.
  • 3,132 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.